idebenone has been researched along with MELAS in 3 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27months." | 7.77 | Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. ( Cho, TH; Derex, L; Kouamé-Assouan, AE; Lekoubou, A; Luauté, J; Nighoghossian, N, 2011) |
| "We report a patient with MELAS treated for 24 months with idebenone and riboflavin, during which no stroke-like episodes occurred." | 7.70 | Long-term treatment with idebenone and riboflavin in a patient with MELAS. ( Giraldi, C; Lombardi, V; Napolitano, A; Salvetti, S; Siciliano, G; Vista, M, 2000) |
| "We report a 36-year-old man with MELAS in whom a 5-month course of high-dose oral idebenone, a derivative of coenzyme Q10, increased markedly cerebral metabolic ratio of oxygen and oxygen extraction fraction without increased cerebral blood flow with PET." | 7.69 | Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. ( Ikejiri, Y; Ishii, K; Mori, E; Nishimoto, K; Sasaki, M; Yasuda, M, 1996) |
| "A 38-year-old patient with MELAS and SLEs was treated with oral L-arginine and idebenone for 27months." | 3.77 | Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient. ( Cho, TH; Derex, L; Kouamé-Assouan, AE; Lekoubou, A; Luauté, J; Nighoghossian, N, 2011) |
| "We report a patient with MELAS treated for 24 months with idebenone and riboflavin, during which no stroke-like episodes occurred." | 3.70 | Long-term treatment with idebenone and riboflavin in a patient with MELAS. ( Giraldi, C; Lombardi, V; Napolitano, A; Salvetti, S; Siciliano, G; Vista, M, 2000) |
| "We report a 36-year-old man with MELAS in whom a 5-month course of high-dose oral idebenone, a derivative of coenzyme Q10, increased markedly cerebral metabolic ratio of oxygen and oxygen extraction fraction without increased cerebral blood flow with PET." | 3.69 | Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS. ( Ikejiri, Y; Ishii, K; Mori, E; Nishimoto, K; Sasaki, M; Yasuda, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lekoubou, A | 1 |
| Kouamé-Assouan, AE | 1 |
| Cho, TH | 1 |
| Luauté, J | 1 |
| Nighoghossian, N | 1 |
| Derex, L | 1 |
| Ikejiri, Y | 1 |
| Mori, E | 1 |
| Ishii, K | 1 |
| Nishimoto, K | 1 |
| Yasuda, M | 1 |
| Sasaki, M | 1 |
| Napolitano, A | 1 |
| Salvetti, S | 1 |
| Vista, M | 1 |
| Lombardi, V | 1 |
| Siciliano, G | 1 |
| Giraldi, C | 1 |
3 other studies available for idebenone and MELAS
| Article | Year |
|---|---|
Effect of long-term oral treatment with L-arginine and idebenone on the prevention of stroke-like episodes in an adult MELAS patient.
Topics: Administration, Oral; Adult; Antioxidants; Arginine; Drug Combinations; Female; Humans; MELAS Syndro | 2011 |
Idebenone improves cerebral mitochondrial oxidative metabolism in a patient with MELAS.
Topics: Adult; Benzoquinones; Brain; Humans; Magnetic Resonance Imaging; Male; MELAS Syndrome; Mitochondria; | 1996 |
Long-term treatment with idebenone and riboflavin in a patient with MELAS.
Topics: Adult; Antioxidants; Aphasia, Wernicke; Benzoquinones; Cerebral Cortex; Cerebral Infarction; Drug Ad | 2000 |